New Heart-Nerve Therapy Diminishes Fainting Spells in Cardioinhibitory Syncope
A new procedure called cardioneuroablation targets the heart’s vagus nerve pathways to reduce pauses in beating that cause fainting in cardioinhibitory syncope. Early results presented at a cardiovascular conference show 25 patients had markedly fewer fainting episodes (averaging under one per year) after treatment, with the broader series reaching 52 patients overall. While promising, the approach is still being studied, not yet peer‑reviewed, and longer-term durability remains to be established, especially as an alternative to pacemakers.